Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Opexa to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Nov 04, 2008 07:31 AM
- Opexa Therapeutics Reports Third Quarter 2008 Financial Results
Oct 23, 2008 08:19 AM
- Opexa Provides Additional Promising Data Including Statistically Significant Reduction in Disability With Tovaxin(R) for the Treatment of Multiple Sclerosis
Oct 23, 2008 07:16 AM
- Opexa to Host Third Quarter Financial Results and Corporate Update Conference Call on October 23, 2008
Oct 20, 2008 04:42 PM
- Opexa Announces Top-Line Results from Phase IIb Clinical Trial of Tovaxin(R) for the Treatment of Multiple Sclerosis
Sep 19, 2008 02:56 PM
- Top-Line Data from Opexa's Phase IIb Tovaxin(R) Study to be Presented at World Congress on Treatment and Research in Multiple Sclerosis
Sep 11, 2008 07:34 AM
- Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program
Sep 03, 2008 07:33 AM
- Opexa Therapeutics Reports Second Quarter 2008 Financial Results and Recent Corporate Highlights
Aug 14, 2008 07:32 AM
- Opexa Therapeutics Completes $3 Million Financing
Aug 13, 2008 07:31 AM
- Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis
Jul 22, 2008 08:01 AM
- Form 4 Opexa Therapeutics, Inc. For: Sep 19 Filed by: STARK BRIAN JAY (10K)
Sep 23, 2008 06:27 PM
- Form 4 Opexa Therapeutics, Inc. For: Sep 02 Filed by: MARXE AUSTIN W & GREENHOUSE DAVID M (10K)
Sep 04, 2008 06:22 PM
- Form 4 Opexa Therapeutics, Inc. For: Aug 19 Filed by: JORDEN DAVID EMERSON (10K)
Aug 21, 2008 05:52 PM
- Form 4 Opexa Therapeutics, Inc. For: Aug 11 Filed by: Hung David (10K)
Aug 13, 2008 12:26 PM
- Form 4 Opexa Therapeutics, Inc. For: Aug 11 Filed by: Seaman Scott B (10K)
Aug 13, 2008 12:25 PM
- Form 4 Opexa Therapeutics, Inc. For: Aug 11 Filed by: Warma Neil K (10K)
Aug 13, 2008 12:18 PM
- Form 4 Seaman Scott B For: Jun 26 (10K)
Jun 30, 2008 06:28 PM
- Form 4 Richman Michael For: Jun 26 (10K)
Jun 30, 2008 06:20 PM
- Form 4 Randall Lorin For: Jun 26 (10K)
Jun 30, 2008 06:17 PM
- Form 4 Hung David For: Jun 26 (10K)
Jun 30, 2008 06:11 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
OPXA
|
Compare to S&P
|
| YTD |
-93.83 %
|
-0.01 %
|
| 4 Weeks |
-25.05 %
|
-11.19 %
|
| 12 Weeks |
-92.50 %
|
-89.19 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 22.22 %
|
|
EPS Growth in Last Year: 52.54 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
